FSDC News and Press, FS Development Corp.

Pardes Biosciences, a developer of a COVID-19 pill named PBI-0451, plans to go public via a merger with blank check company FS Development Corp II (NASDAQ:FSDC), Reuters reports. A shareholder vote in this regard is scheduled for Thursday. Unlike the COVID-19 pill develope...

FS Development II (FSDC) has priced its upsized initial public offering of 17.5M Class A common stock (from 10M) at $10/share.Shares will begin trading today on Nasdaq.Offering is expected to close on February 19.Underwriters' over-allotment is an additional 2.625M shares.SPAC inetn...

Biotech stock Gemini Therapeutics (GMTX) fell nearly 8% on its opening day of Nasdaq trading Monday following a merger with a SPAC, but CEO Jason Meyenburg isn’t worried. “If there were some real event that were driving the company down a little bit in price today, I think [that...

Foresite Capital sponsored FS Development Corp. (FSDC) and precision medicine company Gemini Therapeutics have entered into a definitive merger agreement creating a new company focused on age-related macular degeneration.Current Gemini shareholders are converting 100% of their existing e...

A special purpose acquisition company (SPAC) is a publicly traded shell company that raises capital with the intent of acquiring a private business. SPACs have become an intriguing alternative for companies that want to go public because they allow that to happen much faster than with an init...